tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Douglas Miehm, 23 are a HOLD (27.71%), 60 are a BUY (72.29%).
Analyst Douglas Miehm, currently employed at RBC, carries an average stock price target met ratio of 59.11% that have a potential upside of 25.53% achieved within 170 days.
Douglas Miehm’s has documented 164 price targets and ratings displayed on 6 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on AUPH, Aurinia Pharmaceuticals at 07-Aug-2026.
Analyst best performing recommendations are on AUPH (AURINIA PHARMACEUTICALS).
The best stock recommendation documented was for BHC (BAUSCH HEALTH COMPANIES) at 5/5/2023. The price target of $8 was fulfilled within 13 days with a profit of $2.17 (37.22%) receiving and performance score of 28.63.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Hold Since 07-Aug-2026
$16
$-0.65 (-3.90%)
$15
Buy Since 06-Oct-2016
$16
$-1.23 (-7.14%)
$10
Hold Since 02-May-2024
$21
$3.77 (21.88%)
Buy Since 30-Jul-2025
$17
$-0.23 (-1.33%)
Buy Since 15-Feb-2024
$11
$-6.23 (-36.16%)
$11
Which stock is Douglas Miehm is most bullish on?
Which stock is Douglas Miehm is most reserved on?
What Year was the first public recommendation made by Douglas Miehm?
